To compare dose to organs at risk (OARs) and dose-escalation possibility for 24 stage I non-small cell lung cancer (NSCLC) patients in a ROCOCO (Radiation Oncology Collaborative Comparison) trial.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2DmTDhX
Δευτέρα 12 Μαρτίου 2018
Photons, protons or carbon ions for stage I non-small cell lung cancer – Results of the multicentric ROCOCO in silico study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 4 January 2018 Source: European Journal of Radiology Author(s): Peiyao Zhang, Jing Wang, Qin Xu, Zhen...
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation. Brain Topogr. 2017 Nov 23;: Authors: Wirsich J...
-
Abstract Diphenylarsinic acid (DPAA) is an organic arsenic compound used for the synthesis of chemical weapons. We previously found that th...
-
To evaluate the effect of Recurrence Score® results (RS; Oncotype DX® multigene assay ODX) on treatment recommendations by Swiss multidiscip...
-
Pugazhenthan Thangaraju, Sajitha Venkatesan, MK Showkath Ali Indian Journal of Community Medicine 2018 43(1):58-59 from #AlexandrosSfa...
-
IJMS, Vol. 18, Pages 1601: Updated Insight into the Physiological and Pathological Roles of the Retromer Complex International Journal of M...
-
2016-10-20T01-26-57Z Source: International Journal of Advances in Medicine Sifna Tahir, Altaf Ahmad Mir, Abdul Hameed. Background: Post...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου